医疗保健 · Healthcare

SYRE · Spyre Therapeutics, Inc.

内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22

Spyre Therapeutics, Inc.（SYRE）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $19.6M；高管董事有效买入 —、有效卖出 —。最近申报 2026-10-02。

买入 Bought—

卖出 Sold$19.6M

有效买入 Effective bought—

有效卖出 Effective sold—

最近申报 Recent filings

交易日	内部人	类型	股数	价格	金额
2026-09-30	Burrows Scott L Chief Financial Officer	卖出 Sell	25,000	$90.47	$2.3M	SEC
2026-10-01	King-Jones Heidy See Remarks	卖出 Sell	28,933	$91.03	$2.6M	SEC
2026-10-01	Turtle Cameron Chief Executive Officer, Director	卖出 Sell	15,000	$92.01	$1.4M	SEC
2026-09-01	Burrows Scott L Chief Financial Officer	卖出 Sell	25,732	$88.75	$2.3M	SEC
2026-09-01	King-Jones Heidy See Remarks	卖出 Sell	28,399	$87.35	$2.5M	SEC
2026-09-01	Turtle Cameron Chief Executive Officer, Director	卖出 Sell	15,000	$87.29	$1.3M	SEC
2026-08-07	Albers Jeffrey W. Director	卖出 Sell	23,000	$104.53	$2.4M	SEC
2026-08-03	Burrows Scott L Chief Financial Officer	卖出 Sell	7,500	$95.57	$717K	SEC
2026-08-03	Turtle Cameron Chief Executive Officer, Director	卖出 Sell	15,000	$95.51	$1.4M	SEC
2026-07-01	Burrows Scott L Chief Financial Officer	卖出 Sell	7,500	$87.74	$658K	SEC
2026-07-01	Sloan Sheldon Chief Medical Officer	卖出 Sell	8,334	$87.70	$731K	SEC
2026-07-01	Turtle Cameron Chief Executive Officer, Director	卖出 Sell	15,000	$87.69	$1.3M	SEC

「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。

预计出售日	申报人	股数	约金额
2026-10-01	Turtle Cameron Director, Officer	45,000	$4.0M	10b5-1
2026-10-01	King-Jones Heidy Officer	29,335	$2.6M	10b5-1
2026-09-30	Burrows Scott L Officer	17,500	$1.6M
2026-09-01	King-Jones Heidy Officer	46,665	$4.2M	10b5-1
2026-08-07	Albers Jeffrey W. Director	18,000	$1.9M	10b5-1
2026-08-07	Albers Jeffrey W. Director	5,000	$517K	10b5-1
2026-08-03	Burrows Scott L Officer	30,000	$2.9M	10b5-1
2026-07-01	Turtle Cameron Director, Officer	45,000	$4.0M	10b5-1

Burrows Scott L、King-Jones Heidy、Turtle Cameron、Albers Jeffrey W.、Sloan Sheldon